<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font17">with </span>
   <span class="font17">for </span>
   <span class="font16">COVID- </span>
   <span class="font14">patients </span>
   <span class="font14">{background </span>
   <span class="font14">[]. </span>
   <span class="font14">treatment </span>
   <span class="font13">respiratory </span>
   <span class="font13">coronavirus </span>
   <span class="font13">disease </span>
   <span class="font13">margin </span>
   <span class="font13">are </span>
   <span class="font13">{border-style </span>
   <span class="font13">px;} </span>
   <span class="font13">severe </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">has </span>
   <span class="font12">acute </span>
   <span class="font12">been </span>
   <span class="font12">response </span>
   <span class="font12">from </span>
   <span class="font12">viral </span>
   <span class="font11">clinical </span>
   <span class="font11">infection </span>
   <span class="font11">syndrome </span>
   <span class="font11">that </span>
   <span class="font11">Accessed </span>
   <span class="font11">Apr </span>
   <span class="font11">immune </span>
   <span class="font11">risk </span>
   <span class="font11">atopic </span>
   <span class="font11">immunosuppressive </span>
   <span class="font11">The </span>
   <span class="font11">associated </span>
   <span class="font11">biologic </span>
   <span class="font11">cases </span>
   <span class="font11">have </span>
   <span class="font11">including </span>
   <span class="font11">may </span>
   <span class="font11">might </span>
   <span class="font11">not </span>
   <span class="font11">px; </span>
   <span class="font11">{font-family </span>
   <span class="font11">(COVID-) </span>
   <span class="font11">[], </span>
   <span class="font11">but </span>
   <span class="font11">dermatitis, </span>
   <span class="font11">font-size </span>
   <span class="font11">other </span>
   <span class="font11">psoriasis, </span>
   <span class="font11">those </span>
   <span class="font11">Clin </span>
   <span class="font11">also </span>
   <span class="font11">double; </span>
   <span class="font11">during </span>
   <span class="font11">hidradenitis </span>
   <span class="font11">immune-mediated </span>
   <span class="font11">immunomodulatory </span>
   <span class="font11">infections </span>
   <span class="font11">lung </span>
   <span class="font11">management </span>
   <span class="font11">reported </span>
   <span class="font11">such </span>
   <span class="font11">use </span>
   <span class="font11">which </span>
   <span class="font11">who </span>
   <span class="font11">â€œcytokine </span>
   <span class="font10">Health </span>
   <span class="font10">TNFÎ± </span>
   <span class="font10">and/or </span>
   <span class="font10">antiviral </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">chronic </span>
   <span class="font10">control </span>
   <span class="font10">cutaneous </span>
   <span class="font10">distress </span>
   <span class="font10">drugs </span>
   <span class="font10">host </span>
   <span class="font10">kinase </span>
   <span class="font10">levels </span>
   <span class="font10">novel </span>
   <span class="font10">potential </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">stormâ€� </span>
   <span class="font10">their </span>
   <span class="font10">these </span>
   <span class="font10">was </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(%), </span>
   <span class="font10">Acad </span>
   <span class="font10">COVID-. </span>
   <span class="font10">However, </span>
   <span class="font10">IL- </span>
   <span class="font10">Infect </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">bold </span>
   <span class="font10">cases, </span>
   <span class="font10">caused </span>
   <span class="font10">cells </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokine </span>
   <span class="font10">disease, </span>
   <span class="font10">due </span>
   <span class="font10">em; </span>
   <span class="font10">factor </span>
   <span class="font10">failure, </span>
   <span class="font10">generally </span>
   <span class="font10">high </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">immunosuppressants </span>
   <span class="font10">important </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibitors </span>
   <span class="font10">most </span>
   <span class="font10">new </span>
   <span class="font10">observed </span>
   <span class="font10">outbreak. </span>
   <span class="font10">patient </span>
   <span class="font10">poor </span>
   <span class="font10">pt;} </span>
   <span class="font10">pulmonary </span>
   <span class="font10">receiving </span>
   <span class="font10">secondary </span>
   <span class="font10">severity </span>
   <span class="font10">suppurativa, </span>
   <span class="font10">symptoms </span>
   <span class="font10">than </span>
   <span class="font10">this </span>
   <span class="font10">tissue </span>
  </p>
 </body>
</html>
